Search results
Vertex reaches pricing deal with NHS for cystic fibrosis drugs - The Boston Globe
The Boston Globe· 10 hours agoVertex Pharmaceuticals has reached a pricing deal for its cystic fibrosis drugs with the National...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Shares Bought by Fisher Asset Management LLC
ETF DAILY NEWS· 1 day agoFisher Asset Management LLC raised its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 1.3% in the fourth quarter, according to the company ...
Vertex Reaches Pricing Deal With NHS for Cystic Fibrosis Drugs
Bloomberg· 17 hours agoVertex Pharmaceuticals Inc. has reached a pricing deal for its cystic fibrosis drugs with the...
Vertex Energy (NASDAQ:VTNR) Stock Price Passes Below Two Hundred Day Moving Average of $1.71
ETF DAILY NEWS· 1 day agoShares of Vertex Energy, Inc. (NASDAQ:VTNR – Get Free Report) passed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average ...
Vertex Pharmaceuticals (NASDAQ:VRTX): The Best Healthcare Stock to Buy in 2024?
Insider Monkey via Yahoo Finance· 2 days agoSince Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) ranks 7th on the list, it deserves a deeper...
Vertex Pharmaceuticals (VRTX) Stock Dips While Market Gains: Key Facts
Zacks via Yahoo Finance· 2 days agoThe latest trading session saw Vertex Pharmaceuticals (VRTX) ending at $467.28, denoting a -1.35%...
Vertex Pharmaceuticals Incorporated (VRTX): A Promising Feminist Stock To Buy?
Insider Monkey via Yahoo Finance· 6 days agoWe recently compiled a list of the 11 Best Feminist Stocks To Invest In. In this article, we are...
Access to cystic fibrosis drugs approved in England
BBC News· 17 hours agoA deal has been reached to provide NHS patients with continued access to crucial drugs that treat the life-limiting condition cystic fibrosis. Officials...
Appleton Partners Inc. MA Decreases Stake in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
ETF DAILY NEWS· 2 days agoAppleton Partners Inc. MA lowered its position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 10.6% in the 1st quarter, according to the company in ...
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $550.00
ETF DAILY NEWS· 4 days agoVertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price objective hoisted by equities researchers at Argus from $465.00 to $550.00 in a note issued to investors ...